Farther Finance Advisors
EWTX icon

Farther Finance Advisors’s Edgewise Therapeutics EWTX Stock Holding History

Farther Finance Advisors’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.3K Sell
525
-33
-6% -$1.4K ﹤0.01% 4089
2026
Q2 		$22.7K Sell
558
-87
-13% -$3K ﹤0.01% 3883
2026
Q1 		$21.4K Sell
645
-14
-2% -$404 ﹤0.01% 3613
2025
Q4 		$16.4K Buy
659
+101
+18% +$2.03K ﹤0.01% 3572
2025
Q3 		$9.05K Buy
558
+184
+49% +$2.61K ﹤0.01% 3484
2025
Q2 		$4.9K Buy
374
+366
+4,575% +$5.28K ﹤0.01% 3366
2025
Q1 		$161 Hold
8
– – ﹤0.01% 3989
2024
Q4 		$214 Hold
8
– – ﹤0.01% 3646
2024
Q3 		$214 Sell
8
-12
-60% -$239 ﹤0.01% 3635
2024
Q2 		$388 Buy
20
+12
+150% +$209 ﹤0.01% 3332
2024
Q1 		$144 Hold
8
– – ﹤0.01% 3325
2023
Q4 		$88 Buy
+8
New +$56 ﹤0.01% 3319

Other funds holding EWTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.68B AUM 19.3% 1-Year Est. Return

Farther Finance Advisors's EWTX Position: Q3 2026 in Review

Farther Finance Advisors reduced its Edgewise Therapeutics (EWTX) stake by 5.9% in Q3 2026, selling an estimated $1.4K and leaving 525 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4089.

Farther Finance Advisors first reported a position in EWTX in Q4 2023 and has held it in 12 quarters since. The position peaked at $22.7K in Q2 2026. 9 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

  • Farther Finance Advisors held 525 shares of Edgewise Therapeutics worth $21.3K as of Q3 2026.
  • Farther Finance Advisors sold 33 Edgewise Therapeutics shares in Q3 2026, an estimated $1.4K.
  • Edgewise Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4089 holding.
  • Farther Finance Advisors first reported a position in Edgewise Therapeutics in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Edgewise Therapeutics position peaked at $22.7K in Q2 2026.
  • 9 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.